Unicycive Therapeutics
(NASDAQ) UNCY
Unicycive Therapeutics Financials at a Glance
Market Cap
$194.58M
Revenue (TTM)
$0.00
Net Income (TTM)
$26.55M
EPS (TTM)
$-2.02
P/E Ratio
-3.81
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$7.36
Volume
16,792
Open
$7.69
Price
$7.36
Volume
16,792
Open
$7.69
Previous Close
$7.36
Daily Range
$7.36 - $7.70
52-Week Range
$3.71 - $11.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$7.36
Volume
16,792
Open
$7.69
Previous Close
$7.36
Daily Range
$7.36 - $7.70
52-Week Range
$3.71 - $11.00
UNCY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Unicycive Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
21
CEO
Shalabh Gupta, MD
Website
www.unicycive.comHeadquarters
Los Altos, CA 94022, US
UNCY Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-141%
Return on Capital
-98%
Return on Assets
-54%
Earnings Yield
-26.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$194.58M
Shares Outstanding
25.24M
Volume
16.79K
Short Interest
0.00%
Avg. Volume
556.31K
Financials (TTM)
Gross Profit
$572.00K
Operating Income
$29.52M
EBITDA
$25.91M
Operating Cash Flow
$31.32M
Capital Expenditure
$24.00K
Free Cash Flow
$31.34M
Cash & ST Invst.
$41.27M
Total Debt
$117.00K
Unicycive Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$151.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$194.58M
N/A
Market Cap/Employee
$8.84M
N/A
Employees
22
N/A
Net Income
$14.67M
+31.9%
EBITDA
$14.49M
-56.6%
Quarterly Fundamentals
Net Cash
$41.15M
+62.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$117.00K
-82.2%
Return on Assets
-54.04%
N/A
Return on Invested Capital
-97.75%
N/A
Free Cash Flow
$8.03M
-22.3%
Operating Cash Flow
$8.03M
-22.7%